Thailand Anti-Infective Agents Market Size & Outlook
The anti-infective agents market in Thailand is expected to reach a projected revenue of US$ 453.7 million by 2033. A compound annual growth rate of 2.5% is expected of Thailand anti-infective agents market from 2026 to 2033.
The Thailand anti-infective agents market generated a revenue of USD 387.0 million in 2025 and is expected to reach USD 453.7 million by 2033.
The Thailand market is expected to grow at a CAGR of 2.5% from 2026 to 2033.
In terms of segment, antivirals was the largest revenue generating type in 2025.
Antifungals is the most lucrative type segment registering the fastest growth during the forecast period.
Anti-infective agents market data book summary
Market revenue in 2025
USD 387.0 million
Market revenue in 2033
USD 453.7 million
Growth rate
2.5% (CAGR from 2026 to 2033)
Largest segment
Antivirals
Fastest growing segment
Antifungals
Historical data
2021 - 2024
Base year
2025
Forecast period
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Antibacterials, Antivirals, Antifungals
Key market players worldwide
Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma
Other key industry trends
In terms of revenue, Thailand accounted for 0.3% of the global anti-infective agents market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Asia Pacific, China anti-infective agents market is projected to lead the regional market in terms of revenue in 2033.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 9,943.9 million by 2033.
The anti-infective agents market in Thailand is experiencing considerable growth, driven by the rising prevalence of infectious diseases, particularly tuberculosis (TB). According to the World Health Organization (WHO), the tuberculosis incidence rate was 155 cases per 100,000 people in 2022, indicating a worsening trend compared to 2021.
The latest estimates from UNAIDS reveal that approximately 9,100 people were newly infected with HIV in Thailand in 2023, as reported in the 2024 Global AIDS Report. This combination of increasing infectious diseases emphasizes the necessity for robust research and development in the anti-infective agents market to address these public health concerns effectively.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Anti-infective Agents Market Outlook will help companies and investors design strategic landscapes.
Antivirals was the largest segment with a revenue share of 61.45% in 2025.
Horizon Databook has segmented the Thailand anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2021 to 2033.
The anti-infective agents market in Thailand is experiencing considerable growth, driven by the rising prevalence of infectious diseases, particularly tuberculosis (TB). According to the World Health Organization (WHO), the tuberculosis incidence rate was 155 cases per 100,000 people in 2022, indicating a worsening trend compared to 2021.
The latest estimates from UNAIDS reveal that approximately 9,100 people were newly infected with HIV in Thailand in 2023, as reported in the 2024 Global AIDS Report. This combination of increasing infectious diseases emphasizes the necessity for robust research and development in the anti-infective agents market to address these public health concerns effectively.
Thailand Anti-Infective Agents Market Type Outlook (Revenue, USD Million , 2021-2033)
Antibacterials
Antivirals
Antifungals
Thailand Anti-Infective Agents Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
Oral
Parenteral
Topical
Others
Thailand Anti-Infective Agents Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
Hospital Pharmacies
Retail Pharmacies
Others
Reasons to subscribe to anti infective agents market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of anti infective agents market databook
Our clientele includes a mix of anti infective agents market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand anti infective agents market, including forecasts for subscribers. This country databook contains high-level insights into Thailand anti infective agents market from 2021 to 2033, including revenue numbers, major trends, and company profiles.